Abstract: A rear lamp unit control system for a vehicle including: a first lamp provided on a vehicle body side of a vehicle rear face; a second lamp provided on an opening-closing body side of the vehicle rear face; and a controller configured to control the first lamp and the second lamp. When an opening-closing body of the vehicle is in a closed state, the controller is configured to control the first lamp and the second lamp so that the first lamp and the second lamp turn on at different luminous intensities to each other. In response to the second lamp being in need to be turned on when the opening-closing body is in an open state, the controller is configured to turn the first lamp on at a luminous intensity that is equivalent to a luminous intensity of the second lamp when the second lamp is turned on.

Abstract: A rear lamp unit control system for a vehicle including: a first lamp provided on a vehicle body side of a vehicle rear face; a second lamp provided on an opening-closing body side of the vehicle rear face; and a controller configured to control the first lamp and the second lamp. When an opening-closing body of the vehicle is in a closed state, the controller is configured to control the first lamp and the second lamp so that the first lamp and the second lamp turn on at different luminous intensities to each other. In response to the second lamp being in need to be turned on when the opening-closing body is in an open state, the controller is configured to turn the first lamp on at a luminous intensity that is equivalent to a luminous intensity of the second lamp when the second lamp is turned on.

Abstract: First lighting bodies are provided to the outer surface of a vehicle body, and second lighting bodies are provided to the outer surface of a trunk lid, which can open/close a trunk. While the trunk lid is closed, a first mode is executed in which the second lighting bodies are lit and the lighting is maintained, and then the first lighting bodies are lit and the lighting is maintained for a prescribed period. When the trunk lid is open, a second mode is executed in which at least the former among the first lighting bodies and the second lighting bodies is lit and the lighting time thereof is set longer than the lighting time of the first lighting bodies in the first mode.

Abstract: First lighting bodies are provided to the outer surface of a vehicle body, and second lighting bodies are provided to the outer surface of a trunk lid, which can open/close a trunk. While the trunk lid is closed, a first mode is executed in which the second lighting bodies are lit and the lighting is maintained, and then the first lighting bodies are lit and the lighting is maintained for a prescribed period. When the trunk lid is open, a second mode is executed in which at least the former among the first lighting bodies and the second lighting bodies is lit and the lighting time thereof is set longer than the lighting time of the first lighting bodies in the first mode.

Abstract: A composition for oral preparations, having a complex formed by dispersing or dissolving an unpleasantly tasting basic drug and a functional polymer compound in a substance having a low melting point, 10 to 70% by weight, based on the composition, of sugar alcohol and 0.1 to 7% by weight, based on the composition, of basic oxide. The composition for oral preparation is excellent in masking unpleasantly tasting basic drugs and has excellent performance in biological use.

Abstract: A liposome aqueous suspension containing taurine and benzalkonium chloride is disclosed. The liposome aqueous suspension undergoes no precipitation, agglomeration or change in particle size even when preserved at 40.degree. C. for 6 months and is inhibited from lyso-phospholipid formation.

Abstract: The present invention relates to a process for producing a flavored pharmaceutical preparation for oral administraiton and more particularly to a process for producing a flavored pharmaceutical preparation for oral administration, characterized by spraying, in a moistened and heated air, a suspension of a drug or drug-containing particles dispersed in a cold water solution of polyvinyl acetal diethylaminoacetate, and drying the resulting fine particles. Therefore, the present invention has made it possible to provide a process for producing, at a high yield, a flavored pharmaceutical preparation for oral administration wherein the taste of a drug contained therein is well masked and whose bioavailability is as good as that of a powder of the drug itself.

Abstract: A method of producing a fine coated pharmaceutical preparation, which includes cooling fine liquid droplets composed of a liquid medium, a drug dissolved or suspended in the liquid medium, and as required, a binder to a temperature of not higher than the freezing point of the liquid medium to form frozen particles of the drug and as required the binder, adjusting the particle sizes of the fine frozen particles, mixing the fine frozen particles with a fine powder of a coating material having a particle diameter smaller than the particles at a temperature higher than the freezing point of the liquid medium to cause the fine powder of the coating material to adhere to the surfaces of the particles, and then removing the liquid medium from the resulting coated particles.

Abstract: An optical card for storing data includes a base member and a plurality of parallel linear tracks on the base member for storing the data. Address data is recorded alternately on an opposite end of each successive track for storing an identifying code corresponding to the respective track.

Abstract: An orally administrable pharmaceutical preparation of improved flavoring characteristics composed of a core material containing a drug and a coated layer applied to its surface, said coated layer being composed of a particulate polymeric substance having an average particle diameter of not more than 60 microns and being soluble in gastric juice; and a process for producing said orally administrable pharmaceutical preparation, which comprises causing minute liquid droplets of a volatile liquid containing a drug and optionally a gastric juice-soluble polymeric substance to fall onto a powder bed composed of a gastric juice-soluble particulate polymeric substance having an average particle diameter of not more than 60 microns to coat the surface of the liquid droplets with the gastric juice-soluble particulate polymeric substance, and drying the coated particles.

Abstract: A method of preparing a sustained-release pharmaceutical preparation, which comprises applying a solution of a binder in water or an alcohol and a fine powder of a hydrophobic solid material which does not easily dissolve within the stomach and intestines to the surface of solid particles containing a drug while the solid particles are being tumbled, thereby to coat the solid particles with the binder and the hydrophobic solid material.